FDA Approves New Treatment for Acute Lymphoblastic Leukemia

For patients with relapsed or refractory B - cell ALL who have received one or two prior treatments
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pharmacy, Institutional, Source Type: news